BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...
Column: Trump's appointment of anti-vaxxer RFK Jr. to his Cabinet has scientists fearing a catastrophe for public health
Putting enemies of science in charge of science policy is a formula for mass injury and death, history reminds us.